FDA Alerts

The FDA has approved a generic topical solution for the treatment of chronic, moderately severe psoriasis of the scalp.

The FDA has issued a warning to consumers and health care practitioners about serious injuries and disfigurement from using injectable silicone or products being falsely marketed as FDA-approved dermal fillers.

The FDA has approved Restylane Silk (Galderma) for lip augmentation through the use of a small tip cannula. This is the first FDA-approved hyaluronic acid (HA) dermal filler for lip augmentation and the smoothing of wrinkles around the mouth,...

The FDA has approved a facial filler for temporary improvement in the appearance of moderate to severe forehead lines associated with frontalis muscle activity in adults.

The FDA has approved adalimumab-adbm (Cyltezo), a biosimilar of Humira (adalimumab), for the treatment of multiple inflammatory diseases.